| Drug Name |
Gonadorelin |
| Drug ID |
BADD_D01036 |
| Description |
Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary. |
| Indications and Usage |
For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
H01CA01; V04CM01 |
| DrugBank ID |
DB00644
|
| KEGG ID |
D08027
|
| MeSH ID |
D007987
|
| PubChem ID |
638793
|
| TTD Drug ID |
D04ODH
|
| NDC Product Code |
55463-0016 |
| UNII |
9O7312W37G
|
| Synonyms |
Gonadotropin-Releasing Hormone | Gonadotropin Releasing Hormone | Gn-RH | Gonadoliberin | LHFSH Releasing Hormone | Releasing Hormone, LHFSH | LH-RH | LFRH | LH-Releasing Hormone | LH Releasing Hormone | LH-FSH Releasing Hormone | LH FSH Releasing Hormone | LHFSHRH | LHRH | Luliberin | Gonadorelin | Luteinizing Hormone-Releasing Hormone | Luteinizing Hormone Releasing Hormone | FSH-Releasing Hormone | FSH Releasing Hormone | GnRH | Factrel | Cystorelin | Gonadorelin Hydrochloride | Kryptocur | Dirigestran | Gonadorelin Acetate |
